Quantcast

Latest Biomarker Stories

2014-07-24 08:31:45

SAN DIEGO, July 24, 2014 /PRNewswire/ -- Cypher Genomics, Inc., the genome informatics company, announced today the appointment of Adam Simpson as president and chief operating officer (COO). Cypher Genomics provides rapid and comprehensive annotation and interpretation of individual human genomes for biomarker discovery and clinical reporting. "Cypher's technology has the potential to play a transformative role to improve healthcare by enhancing diagnostic accuracy, optimizing...

2014-07-24 08:31:43

SAN DIEGO, July 24, 2014 /PRNewswire/ -- Cypher Genomics, Inc., the genome informatics company, announced today a co-promotion agreement with Illumina to facilitate the development of genomic-based biomarkers from whole genome sequence data for precision medicine and clinical trials. Cypher Genomics and Illumina will jointly offer pharmaceutical companies, through Illumina's sales force, a solution including Illumina's market leading sequencing technology, the NextBio platform for...

2014-07-15 08:28:42

Highly sensitive and easy-to-use technology validated in over 100 papers in three years; probe library exceeds 4000 HAYWARD, California, July 15, 2014 /PRNewswire/ -- Advanced Cell Diagnostics Inc. (ACD), a leader in the field of molecular pathology and developer of cell and tissue-based analysis tools, announces that its RNAscope(R) RNA in situ hybridization technology has reached two major milestones. In just three years, over 100 peer-reviewed papers featuring the technology...

2014-07-14 23:02:36

The global metabolomics market is consolidated in nature, wherein the top five players account for more than 70%–75% of the market share - http://www.marketsandmarkets.com/Market-Reports/metabolomics-technology-market-900.html. (PRWEB) July 14, 2014 “Metabolomics Market by Technique (Gas Chromatography, High Performance Liquid Chromatography, Nuclear Magnetic Resonance Spectroscopy, Mass Spectrometry, by Application (Biomarker & Drug Discovery, Nutrigenomics), by Indication...

2014-07-10 23:01:03

Scientists from around the world will gather in Copenhagen to release the latest findings in research on diagnostics, treatments, biomarkers, risk factors, and the potential for reducing risks. Denver, Colorado (PRWEB) July 10, 2014 Thousands of researchers from more than 60 countries will gather in Copenhagen this July 13-17 to reveal the latest study results, theories and discoveries bringing the world closer to breakthroughs in dementia science. The Alzheimer’s Association...

2014-07-10 12:30:06

TUCSON, Ariz., July 10, 2014 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced it has entered into an agreement with Merck KGaA, Darmstadt, Germany, which operates as EMD Serono in the United States and Canada, to collaborate with Merck KGaA's biopharmaceutical division on the development and commercialization of a companion diagnostic (CDx) for an undisclosed target using Ventana's proprietary diagnostic assays. In alignment with...

2014-07-07 15:58:52

European League Against Rheumatism Early detection could help prevent severe disease in the most common form of arthritis The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) identify a correlation between the presence of biomarkers in the blood, known as micro RNAs (miRNAs), and the development of severe osteoarthritis (OA) of the knee or hip joint. The findings suggest that miRNAs may be used as biomarkers to predict severe OA...

2014-07-07 08:27:28

VISTA, Calif. and HARTFORD, Conn., July 7, 2014 /PRNewswire/ -- AutoGenomics, Inc, a leader in automated microarray technology for molecular diagnostics, and Genomas, a biomedical company enabling DNA-guided medicine for personal healthcare, announced today that they have signed an agreement to jointly develop genetic tests and DNA-guided diagnostic systems for optimal selection of statins and for improved delivery of statin therapy for the treatment of cardiovascular disease, obesity...

2014-07-03 23:00:57

Transparency Market Research has announced the addition of the "Molecular Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" report to their offering. Browse the full report: http://www.transparencymarketresearch.com/molecular-diagnostics-industry.html. Albany, New York (PRWEB) July 04, 2014 Molecular diagnostics is the class of diagnostic test that explores and evaluates nucleic acids or proteins at a molecular level. Our...

2014-07-01 16:30:01

CASTLE ROCK, Colo., July 1, 2014 /PRNewswire/ -- Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance and commercializing its CE Marked APPY1(TM) Test, a rapid, multiple biomarker-based assay for identifying patients that are at low risk for appendicitis, today announced it will participate in the third annual ICV Company Outreach Summit, being held July 9-10, 2014, in Montauk, New York. Steve Lundy, President and CEO of Venaxis® will be...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related